drugset / Trial / NCT01063842

A Study of the Tolerability of Titrated Dose Tramadol/Acetaminophen Combination Tablet in Korean Patients With Osteoarthritis

NCT01063842

Phase 4 Completed 250 enrolled Janssen Korea, Ltd., Korea
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the number of osteoarthritis patients receiving titrated or increasing doses of tramadol hydrochloride/acetaminophen combination tablet (titration group) who discontinue treatment due to adverse events to the number of patients receiving a non-titrated dose of tramadol/hydrochloride/acetaminophen combination tablet who discontinue treatment due to adverse events.

Timeline

Start
2005-08
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule
Subject Tramadol Other / unclassified

Indications